Nr Chembiosciences (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 488.28%
- Profit Growth 35.70%
- Ebitda 289.03%
- Net Worth 84.30%
- Total Assets 736.79%
About Nr Chembiosciences (Opc)
Nr Chembiosciences (Opc) Private Limited (NCOPL) is a Company incorporated in India on 12 April 2018 (Six years and nine months 30 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Revathi Bandi serves as a director at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299TG2018OPC123822
-
Company No.
123822
-
Incorporation Date
12 Apr 2018
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Nr Chembiosciences (Opc) Private Limited offer?
Nr Chembiosciences (Opc) Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic & Herbal Extracts, Herbal Extracts, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Plant Extracts, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Chemical Reagents & Catalysts.
Who are the key members and board of directors at Nr Chembiosciences (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Revathi Bandi
|
Director | 12-Apr-2018 | Current |
Financial Performance of Nr Chembiosciences (Opc).
Nr Chembiosciences (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 488.28% increase. The company also saw a substantial improvement in profitability, with a 35.7% increase in profit. The company's net worth Soared by an impressive increase of 84.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nr Chembiosciences (Opc)?
In 2022, Nr Chembiosciences (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nr Chembiosciences (Opc)?
Unlock and access historical data on people associated with Nr Chembiosciences (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nr Chembiosciences (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nr Chembiosciences (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.